ISSN: 0040-6376

Journal Home

Journal Guideline

Thorax Q1 Unclaimed

BMJ Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Thorax is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 252. It has an SJR impact factor of 3,001 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,001.

Thorax focuses its scope in these topics and keywords: sleep, obstructive, respiratory, health, disease, chronic, tuberculosis, patients, pulmonary, pneumonia, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pulmonary and Respiratory Medicine (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,001

SJR Impact factor

252

H Index

225

Total Docs (Last Year)

675

Total Docs (3 years)

7464

Total Refs

3952

Total Cites (3 years)

497

Citable Docs (3 years)

6.14

Cites/Doc (2 years)

33.17

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Lancet Respiratory Medicine,The Q1
The Lancet Respiratory Medicine Q1
Journal of Thoracic Oncology Q1
American Journal of Respiratory and Critical Care Medicine Q1
European Respiratory Journal Q1

Compare this journals

Aims and Scope

Best articles by citations

Squawks in pneumonia

Rapid detection of pneumococcal antigen in pleural fluid of patients with community acquired pneumonia.

Community-acquired pneumonia in children: what's new?

Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients

Inhibition of the alveolar macrophage oxidative burst by a diffusible component from the surface of the spores of the fungus Aspergillus fumigatus.

Pulmonary pseudotumour due to Corynebacterium equi in a patient with the acquired immunodeficiency syndrome.

Coming now to a chest clinic near you

Highlights from this issue

Prospective study of mycobacterial infections in patients with cystic fibrosis.

Investigation of mycobacterial colonisation and invasion of the respiratory mucosa

Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus.

Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis

SHOW MORE ARTICLES

Lymphangioleiomyomatosis: a case-control study of perinatal and early life events

Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster

Functional brain imaging in respiratory medicine

Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin

Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF

Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial

Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping

Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection.

Cryptococcosis in HIV negative patients: findings on chest radiography

Disseminated Penicillium marneffei infection presenting as a right upper lobe mass in an HIV positive patient

Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis.

Effect of bacterial products on human ciliary function in vitro.